Four months since its approval for use in the UK, the Oxford/AstraZeneca vaccine has been administered to tens of millions of people across the country. However, due to a possible link with rare blood clots, people under 30 will now be offered an alternative coronavirus vaccine (where available) after a recommendation from...
Read Full StoryIf the content contained herein violates any of your rights, including those of copyright, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com
Top News
Related
DISEASE PREVENTION AND TREATMENT
Paracetamol overdose: Two ‘extremely common’ side effects of overdosing paracetamol
, 7min
0
DISEASE PREVENTION AND TREATMENT
AstraZeneca blood clotting: what is this rare syndrome and how is it caused?
, 10min
0
, 38min
0
DISEASE PREVENTION AND TREATMENT
Return to crowded A&Es and long ambulance delays will put patients at risk, warn experts
, 54min
0
DISEASE PREVENTION AND TREATMENT
'New motor neurone disease research is glimmer of hope for devastating illness'
, 57min
0
DISEASE PREVENTION AND TREATMENT
Republic's advisory panel recommends AstraZeneca restriction
, 1h
0
DISEASE PREVENTION AND TREATMENT
Irish advisory panel: AstraZeneca vaccine should not be given to people under 60
, 1h
0
DISEASE PREVENTION AND TREATMENT
Teenager with eating disorder 'told her BMI wasn't low enough to get help'
, 1h
0
DISEASE PREVENTION AND TREATMENT
Oxford-AstraZeneca vaccine 'not recommended' for under-60s in Ireland over blood clot fears
, 1h
0
DISEASE PREVENTION AND TREATMENT
Pandemic hits ‘critical point’ as Europe deaths top one million
, 1h
0
DISEASE PREVENTION AND TREATMENT
Largest surge testing to date deployed in two London boroughs after South African variant confirmed
, 1h
0
DISEASE PREVENTION AND TREATMENT
Testing surge after dozens contract South African virus variant in south London
, 2h
0
comments